Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The phosphatidylinositol-protein nanocomplex as a new biosensor for ecological monitoring and clinical diagnostic.
Biosens Bioelectron. 2009 Jan 1;24(5):1490-2. doi: 10.1016/j.bios.2008.05.009. Epub 2008 Jul 7.
Biosens Bioelectron. 2009.
PMID: 18603423
The main feature of nanocomplex is its high sensitivity to ammonia ions. Linear response concentration for nanocomplex is from 0.5 microM to 10 microM ammonia ions. ...
The main feature of nanocomplex is its high sensitivity to ammonia ions. Linear response concentration for nanocomplex is from 0.5 mi …
[Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
Geppe NA, Kondiurina EG, Galustian AN, Pak TE, Bal'tserovich NB, Zhiglinskaia OV, Kamaev AV, Lazareva SG, Laléko SL, Mel'nikova IM, Perminova OA, Sabitov AU.
Geppe NA, et al.
Antibiot Khimioter. 2014;59(5-6):6-14.
Antibiot Khimioter. 2014.
PMID: 25552038
Clinical Trial.
Russian.
In Ergoferon group, the percentage of non-fever subjects, with the endpoint defined at 37.2 degrees C, was 43% on Day 2, as estimated in the morning and the evening (vs 25% and 19% in the placebo group, respectively; chi2 = 10.6; p = 0.012), and 83% in the morning and 84% in the …
In Ergoferon group, the percentage of non-fever subjects, with the endpoint defined at 37.2 degrees C, was 43% on Day 2, as estimated in the …
Item in Clipboard
Cite
Cite